Tolvaptan substitution for torsemide is associated with improved renal biomarkers in dogs with advanced myxomatous mitral valve disease and concurrent azotemia
{{output}}
Objective: To evaluate the safety and preliminary efficacy of substituting torsemide with tolvaptan on renal biomarkers in dogs with myxomatous mitral valve disease (MMVD) and concurrent azotemia. ... ...
